我们测量的是真正重要的指标吗?牙髓病学中的替代终点陷阱
本文为社论,讨论牙髓病研究中替代终点的益处与局限,指出替代终点仅评估间接生物学或技术过程,而非患者最关心的长期患牙存留、功能、无症状及口腔健康相关生活质量。作者提出按生物学相关性和与临床有意义结局关联强度对替代指标分类的概念框架,并主张常规整合患者报告结局指标和标准化核心结局集。
要点
- 替代终点便于在实用时间框架内评估治疗、材料和技术,但不直接反映患者重要结局。
- 技术或实验室指标的改善不一定转化为更好的患者结局。
- 新兴技术主要提高替代测量的精确性,而非克服其固有局限。
核心结论
- 替代终点应继续支持科学进步,但其解读必须锚定于真正反映患者视角治疗成功的结局。
研究设计与样本
- 社论,未报告系统检索范围或样本量。
主要发现
- 替代终点评估间接生物学或技术过程,而非长期患牙存留、功能、无症状及口腔健康相关生活质量等患者重要结局。
- 替代终点的广泛使用不仅反映方法学便利,也反映直接评估根管感染及其与愈合关系的基本能力不足。
- 锥形束计算机断层扫描、分子诊断、生物标志物和人工智能等新兴技术主要提高替代测量的精确性,而非克服其固有局限。
关键数值与推荐
- 提出按生物学相关性和与临床有意义结局关联强度对常用替代指标分类的概念框架。
- 主张通过常规整合患者报告结局指标和标准化核心结局集与常规临床及影像学评估,实现更以患者为中心的结局评估。
临床怎么用
- 在牙髓病临床研究和评估中,应同时关注替代终点与患者重要结局,避免仅凭技术或实验室指标改善判定治疗成功。
- 常规整合患者报告结局指标和标准化核心结局集与临床及影像学评估。
局限性
- 本文为社论,未报告原始研究数据、样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Surrogate endpoints have been important to the advancement of endodontic research, enabling the evaluation of treatments, materials and techniques within practical timeframes. However, these measures assess indirect biological or technical processes rather than the outcomes that matter most to patients, including long-term tooth survival, function, freedom from symptoms and oral health-related quality of life. This editorial examines the benefits and limitations of surrogate endpoints in endodontics, arguing that their widespread use reflects not only methodological convenience but also a fundamental inability to directly assess root canal infection and its relationship with healing. Drawing on examples from medicine and contemporary endodontic research, we discuss the distinction between biological plausibility and clinical validation, emphasizing that improvements in technical or laboratory measures do not necessarily translate into better patient outcomes. A conceptual framework is proposed to classify commonly used surrogate measures according to their biological relevance and the strength of their association with clinically meaningful outcomes. We further consider the impact of emerging technologies, including cone beam computed tomography, molecular diagnostics, biomarkers and artificial intelligence, highlighting that these innovations primarily improve the precision of surrogate measurements rather than overcome their inherent limitations. Finally, we advocate for a more patient-centred approach to outcome assessment through the routine integration of patient-reported outcome measures and standardized core outcome sets alongside conventional clinical and radiographic evaluations. Surrogate endpoints should continue to support scientific progress, but their interpretation must remain anchored to outcomes that genuinely reflect treatment success from the patient's perspective.
引用
- Silva EJNL, De-Deus G, Souza EM, et al. Are We Measuring What Matters? The Surrogate Trap in Endodontics. Int Endod J. 2026. PMID: 42459124. doi:10.1111/iej.70229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。